$HOLX
HOLOGIC INC

2012 Q3 Form 10-Q Financial Statement

#000119312512331820 Filed on August 02, 2012

View on sec.gov

Income Statement

Concept 2012 Q3 2012 Q2 2011 Q2
Revenue $588.5M $470.2M $451.1M
YoY Change 26.02% 4.24% 7.22%
Cost Of Revenue $333.6M $46.25M $42.50M
YoY Change 49.06% 8.81% -79.84%
Gross Profit $274.3M $244.6M $234.6M
YoY Change 12.8% 4.3% 11.75%
Gross Profit Margin 46.61% 52.03% 52.0%
Selling, General & Admin $179.1M $119.8M $112.7M
YoY Change 54.93% 6.26% 22.67%
% of Gross Profit 65.29% 48.97% 48.06%
Research & Development $51.60M $26.23M $29.33M
YoY Change 78.55% -10.56% 14.11%
% of Gross Profit 18.81% 10.72% 12.5%
Depreciation & Amortization $114.7M $76.90M $77.10M
YoY Change 46.3% -0.26% 3.49%
% of Gross Profit 41.81% 31.43% 32.87%
Operating Expenses $292.5M $146.0M $142.1M
YoY Change 67.33% 2.79% 8.36%
Operating Profit -$18.18M $80.53M $73.92M
YoY Change -126.58% 8.94% -6.18%
Interest Expense -$56.30M $25.59M $28.67M
YoY Change 96.85% -10.74% -186.11%
% of Operating Profit 31.78% 38.79%
Other Income/Expense, Net $2.000M -$622.0K -$1.304M
YoY Change -162.5% -52.3% -534.67%
Pretax Income -$98.00M $55.01M $44.42M
YoY Change -335.58% 23.82% -2.79%
Income Tax -$20.30M $31.41M $8.228M
% Of Pretax Income 57.11% 18.52%
Net Earnings -$77.77M $23.59M $36.20M
YoY Change -382.08% -34.82% 31.87%
Net Earnings / Revenue -13.21% 5.02% 8.02%
Basic Earnings Per Share $0.09 $0.14
Diluted Earnings Per Share -$0.29 $0.09 $0.14
COMMON SHARES
Basic Shares Outstanding 264.7M shares 264.6M shares 261.8M shares
Diluted Shares Outstanding 267.3M shares 265.2M shares

Balance Sheet

Concept 2012 Q3 2012 Q2 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $560.0M $905.0M $614.0M
YoY Change -21.35% 47.39% 25.05%
Cash & Equivalents $560.4M $905.1M $613.8M
Short-Term Investments
Other Short-Term Assets $226.0M $65.00M $69.00M
YoY Change 179.01% -5.8% -36.11%
Inventory $367.2M $228.5M $233.0M
Prepaid Expenses $44.30M $27.14M
Receivables $409.3M $336.4M $292.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.563B $1.535B $1.208B
YoY Change 16.39% 27.07% 15.16%
LONG-TERM ASSETS
Property, Plant & Equipment $508.0M $232.7M $248.0M
YoY Change 112.85% -6.15% -2.75%
Goodwill $3.943B $2.294B
YoY Change 72.15%
Intangibles $4.301B $1.915B
YoY Change 105.72%
Long-Term Investments
YoY Change
Other Assets $162.1M $50.02M $50.00M
YoY Change 251.73% 0.03% 2.04%
Total Long-Term Assets $8.914B $4.492B $4.729B
YoY Change 91.05% -5.02% 1.0%
TOTAL ASSETS
Total Short-Term Assets $1.563B $1.535B $1.208B
Total Long-Term Assets $8.914B $4.492B $4.729B
Total Assets $10.48B $6.027B $5.937B
YoY Change 74.36% 1.51% 3.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $87.22M $55.06M $52.00M
YoY Change 37.43% 5.89% 0.0%
Accrued Expenses $372.4M $374.9M $290.0M
YoY Change 14.46% 29.26% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $64.44M $0.00
YoY Change -100.0%
Total Short-Term Liabilities $661.3M $557.1M $467.0M
YoY Change 29.82% 19.29% 18.53%
LONG-TERM LIABILITIES
Long-Term Debt $4.971B $1.542B $1.470B
YoY Change 233.95% 4.9% 2.87%
Other Long-Term Liabilities $98.25M $66.15M $119.0M
YoY Change -8.14% -44.41% 70.0%
Total Long-Term Liabilities $5.069B $66.15M $1.589B
YoY Change 217.72% -95.84% 6.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $661.3M $557.1M $467.0M
Total Long-Term Liabilities $5.069B $66.15M $1.589B
Total Liabilities $7.516B $623.3M $3.027B
YoY Change 144.67% -79.41% 3.98%
SHAREHOLDERS EQUITY
Retained Earnings -$2.444B -$2.366B
YoY Change 3.11%
Common Stock $2.656M $2.649M
YoY Change 1.18%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.518M $1.518M
YoY Change 0.0%
Treasury Stock Shares 219.0K shares 219.0K shares
Shareholders Equity $2.961B $3.004B $2.910B
YoY Change
Total Liabilities & Shareholders Equity $10.48B $6.027B $5.937B
YoY Change 74.36% 1.51% 3.59%

Cashflow Statement

Concept 2012 Q3 2012 Q2 2011 Q2
OPERATING ACTIVITIES
Net Income -$77.77M $23.59M $36.20M
YoY Change -382.08% -34.82% 31.87%
Depreciation, Depletion And Amortization $114.7M $76.90M $77.10M
YoY Change 46.3% -0.26% 3.49%
Cash From Operating Activities $85.60M $71.80M $119.9M
YoY Change -28.01% -40.12% 2.3%
INVESTING ACTIVITIES
Capital Expenditures -$25.40M -$19.80M -$14.90M
YoY Change 93.89% 32.89% 27.35%
Acquisitions
YoY Change
Other Investing Activities -$3.774B -$1.000M -$72.10M
YoY Change 48278.21% -98.61% -6108.33%
Cash From Investing Activities -$3.799B -$20.80M -$87.00M
YoY Change 18076.56% -76.09% 720.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.368B 300.0K 7.400M
YoY Change 240464.29% -95.95% -116.09%
NET CHANGE
Cash From Operating Activities 85.60M 71.80M 119.9M
Cash From Investing Activities -3.799B -20.80M -87.00M
Cash From Financing Activities 3.368B 300.0K 7.400M
Net Change In Cash -345.4M 51.30M 40.30M
YoY Change -447.48% 27.3% -33.5%
FREE CASH FLOW
Cash From Operating Activities $85.60M $71.80M $119.9M
Capital Expenditures -$25.40M -$19.80M -$14.90M
Free Cash Flow $111.0M $91.60M $134.8M
YoY Change -15.91% -32.05% 4.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q1 holx Royalty On Sales Due
RoyaltyOnSalesDue
0.05 pure
CY2012Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
264694835 shares
CY2011Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
111925000
CY2011Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4208000
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
613801000
CY2011Q2 us-gaap Business Acquisition Contingent Consideration At Fair Value
BusinessAcquisitionContingentConsiderationAtFairValue
86600000
CY2011Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
108259000
CY2012Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
96212000
CY2012Q2 us-gaap Restructuring Reserve
RestructuringReserve
2241000
CY2012Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
219000 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2012Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4930000
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1623000 shares
CY2012Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1542146000
CY2012Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2885960000
CY2012Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
314000
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2857000
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
557107000
CY2012Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1725000000
CY2012Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
189019000
CY2012Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
26848000
CY2012Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
127193000
CY2012Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
300000
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2365787000
CY2012Q2 us-gaap Assets
Assets
6026794000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
905082000
CY2012Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
117835000
CY2012Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
12579000
CY2012Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
58629000
CY2012Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
816600000
CY2012Q2 us-gaap Prepaid Taxes
PrepaidTaxes
9738000
CY2012Q2 us-gaap Valuation Allowance Amount
ValuationAllowanceAmount
2600000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.48
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
336437000
CY2012Q2 us-gaap Inventory Net
InventoryNet
228496000
CY2012Q2 us-gaap Fair Value Liabilities Measured On Recurring Basis Obligations
FairValueLiabilitiesMeasuredOnRecurringBasisObligations
106643000
CY2012Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
232301000
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8825000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
15300000 shares
CY2012Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
552338000
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50016000
CY2012Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
524000
CY2012Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
27137000
CY2012Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
844154000
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6026794000
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
264885000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3500000 shares
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
2649000
CY2012Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
971404000
CY2012Q2 us-gaap Land
Land
8630000
CY2012Q2 us-gaap Goodwill
Goodwill
2294492000
CY2012Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.02 pure
CY2012Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
45392000
CY2012Q2 us-gaap Cost Method Investments Aggregate Carrying Amount
CostMethodInvestmentsAggregateCarryingAmount
4900000
CY2012Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1914556000
CY2012Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
202839000
CY2012Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
27570000
CY2012Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Maximum Number Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsMaximumNumberOfShares
75600000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
16.26
CY2012Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1518000
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
374850000
CY2012Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
83813000
CY2012Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
60800000
CY2012Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
232746000
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
12987000
CY2012Q2 us-gaap Assets Current
AssetsCurrent
1534984000
CY2012Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5371764000
CY2012Q2 us-gaap Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
7500000
CY2012Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
217761000
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
319592000
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
3004251000
CY2012Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
66149000
CY2012Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
82936000
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
55064000
CY2012Q2 holx Equipment Under Customer Usage Agreements
EquipmentUnderCustomerUsageAgreements
193939000
CY2012Q2 holx Define Benefit Plan Minimum Funding Requirement Imposed On Employer
DefineBenefitPlanMinimumFundingRequirementImposedOnEmployer
0
CY2012Q2 holx Manufacturing Equipment And Software
ManufacturingEquipmentAndSoftware
233169000
CY2012Q2 holx Additional Amount To Be Received In Eighteen To Thirty Month Period
AdditionalAmountToBeReceivedInEighteenToThirtyMonthPeriod
95000000
CY2012Q2 holx Failure To Comply With Reporting Obligations Penalty Fee Percentage Of Convertible Notes
FailureToComplyWithReportingObligationsPenaltyFeePercentageOfConvertibleNotes
0.0025 pure
CY2012Q2 holx Maximum Redemption Amount
MaximumRedemptionAmount
0.35 pure
CY2010Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2830000
CY2010Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
515625000
CY2010Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
29500000
CY2011Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
219000 shares
CY2011Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2011Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
4448000
CY2011Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1623000 shares
CY2011Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
1488580000
CY2011Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2879705000
CY2011Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1995000
CY2011Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
300000
CY2011Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2369920000
CY2011Q3 us-gaap Liabilities Current
LiabilitiesCurrent
509450000
CY2011Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1725000000
CY2011Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
30217000
CY2011Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
120656000
CY2011Q3 us-gaap Assets
Assets
6008780000
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
712332000
CY2011Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
113682000
CY2011Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
12401000
CY2011Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
58937000
CY2011Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
917800000
CY2011Q3 us-gaap Prepaid Taxes
PrepaidTaxes
10098000
CY2011Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
318712000
CY2011Q3 us-gaap Inventory Net
InventoryNet
230544000
CY2011Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6516000
CY2011Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
519792000
CY2011Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
46077000
CY2011Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
537000
CY2011Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
31070000
CY2011Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
957426000
CY2011Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6008780000
CY2011Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
262459000 shares
CY2011Q3 us-gaap Common Stock Value
CommonStockValue
2625000
CY2011Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
788898000
CY2011Q3 us-gaap Land
Land
8883000
CY2011Q3 us-gaap Goodwill
Goodwill
2290330000
CY2011Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
43554000
CY2011Q3 us-gaap Cost Method Investments Aggregate Carrying Amount
CostMethodInvestmentsAggregateCarryingAmount
4600000
CY2011Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2090807000
CY2011Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
39607000
CY2011Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q3 us-gaap Treasury Stock Value
TreasuryStockValue
1518000
CY2011Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
325327000
CY2011Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
86645000
CY2011Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
238666000
CY2011Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
9467000
CY2011Q3 us-gaap Assets Current
AssetsCurrent
1342900000
CY2011Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5303713000
CY2011Q3 us-gaap Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
8100000
CY2011Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
281126000
CY2011Q3 us-gaap Stockholders Equity
StockholdersEquity
2936895000
CY2011Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
106962000
CY2011Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
103790000
CY2011Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
63467000
CY2011Q3 holx Equipment Under Customer Usage Agreements
EquipmentUnderCustomerUsageAgreements
172614000
CY2011Q3 holx Define Benefit Plan Minimum Funding Requirement Imposed On Employer
DefineBenefitPlanMinimumFundingRequirementImposedOnEmployer
0
CY2011Q3 holx Manufacturing Equipment And Software
ManufacturingEquipmentAndSoftware
223403000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
84502000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
12424000
us-gaap Restructuring Costs
RestructuringCosts
200000
us-gaap Severance Costs
SeveranceCosts
200000
CY2011Q4 holx Loss Contingencies Damages Award To Plaintiff
LossContingenciesDamagesAwardToPlaintiff
18800000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-938000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
25850000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
189800000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
2445000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-245673000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1352000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5327000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.87
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
87817000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3792000
us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
2100000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
260744000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.45 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.303 pure
us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
657000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y2M12D
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3083000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12120000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
185780000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
175320000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
229959000
us-gaap Share Based Compensation
ShareBasedCompensation
27245000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
17.14
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
98176000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
211619000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3021000
us-gaap Operating Income Loss
OperatingIncomeLoss
301024000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1185000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
34731000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
385863000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
226358000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-35346000
us-gaap Net Income Loss
NetIncomeLoss
129581000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
84502000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2200000 shares
us-gaap Costs And Expenses
CostsAndExpenses
1021280000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
119062000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
264114000 shares
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
57363000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6315000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-450000
us-gaap Cost Of Services
CostOfServices
124981000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
138692000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1358000
us-gaap Revenues
Revenues
1322304000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
54438000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
56199000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
419000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1200000 shares
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
24078000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
42535000
us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
131478000
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
5322000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21894000
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
13250000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3268000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43842000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1092345000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
9111000
us-gaap Depreciation
Depreciation
51038000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1820000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
3546000
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
99000
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
1129000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9548000
us-gaap Interest Expense
InterestExpense
85767000
us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
83213000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.23
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8361000
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-3944000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3071000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
337115000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3268000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1015000
holx Change In Other Assets
ChangeInOtherAssets
385000
holx Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
2925000
holx Business Acquisition Contingent Consideration Expense Total
BusinessAcquisitionContingentConsiderationExpenseTotal
670000
holx Entity Wide Disclosure On Geographic Areas From External Customers Attributed To Foreign Countries
EntityWideDisclosureOnGeographicAreasFromExternalCustomersAttributedToForeignCountries
298700000
holx Debt Instrument Convertible Interest Expense Non Cash
DebtInstrumentConvertibleInterestExpenseNonCash
57363000
holx Contingent Consideration Compensation Expense
ContingentConsiderationCompensationExpense
4216000
holx Fair Value Write Up Of Acquired Inventory
FairValueWriteUpOfAcquiredInventory
3298000
holx Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
29891000
holx Payment For Tax Withholding Related To Vested And Released Restricted Stock Units
PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
10394000
holx Payment Of Additional Acquisition Consideration
PaymentOfAdditionalAcquisitionConsideration
19660000
holx Payment Of Contingent Consideration
PaymentOfContingentConsideration
4295000
holx Payment Of Contingent Consideration Liabilities Recorded At Fair Value
PaymentOfContingentConsiderationLiabilitiesRecordedAtFairValue
4295000
holx Payments To Manufacture Equipment Under Customer Usage Agreements
PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
20641000
holx Weighted Average Common Stock Equivalents From Assumed Exercise Of Stock Options And Restricted Stock Units
WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits
3370000 shares
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-06-23
dei Entity Central Index Key
EntityCentralIndexKey
0000859737
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-29
dei Trading Symbol
TradingSymbol
HOLX
dei Entity Registrant Name
EntityRegistrantName
Hologic Inc.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2897000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
25683000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
16435000
us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
One
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51924000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1947000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
7908000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.09
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
83868000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
5632000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
263742000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.47 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
131319000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
266359000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.886 pure
us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M18D
us-gaap Goodwill Other Changes
GoodwillOtherChanges
-4036000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11217000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22055000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
36303000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
182996000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
249330000
us-gaap Share Based Compensation
ShareBasedCompensation
26360000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
17.09
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
126000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
192750000
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2600000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
232367000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
us-gaap Operating Income Loss
OperatingIncomeLoss
157420000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1591000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8959000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
420429000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
231103000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-124253000
us-gaap Net Income Loss
NetIncomeLoss
4133000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
12424000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2100000 shares
us-gaap Costs And Expenses
CostsAndExpenses
1256684000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
54882000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-39763000
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
1166000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-440000
us-gaap Cost Of Services
CostOfServices
137763000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-719000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1356000
us-gaap Revenues
Revenues
1414104000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
52018000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32170000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-194000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1500000 shares
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
21741000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
53442000
us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
135792000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20692000
us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
12500000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3791000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
47204000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1164774000
us-gaap Restructuring Charges
RestructuringCharges
828000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-4852000
us-gaap Depreciation
Depreciation
48107000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2402000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
-35034000
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
250000
us-gaap Severance Costs
SeveranceCosts
138000
us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
900000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
40230000
us-gaap Interest Expense
InterestExpense
83614000
us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
80565000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.43
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8155000
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-360000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
5150000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
284631000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>(17) New Accounting Pronouncements</b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><i>Disclosures about Offsetting Assets and Liabilities</i></font></p> <p style="margin-top:6px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">In December 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No.&#xA0;2011-11, <i>Disclosures about Offsetting Assets and Liabilities</i>.&#xA0;ASU&#xA0;2011-11 amended ASC 210, <i>Balance Sheet,</i> to converge the presentation of offsetting assets and liabilities between U.S. GAAP and IFRS.&#xA0;ASU&#xA0;2011-11 requires that entities disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. ASU 2011-11 is effective for fiscal years, and interim periods within those years, beginning after January&#xA0;1, 2013, which is the Company&#x2019;s fiscal year 2014.&#xA0;The Company is currently evaluating the impact of the adoption of ASU 2011-11 on its consolidated financial statements.</font></p> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><i>Presentation of Comprehensive Income</i></font></p> <p style="margin-top:6px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">In June 2011, the FASB issued ASU No.&#xA0;2011-05, <i>Comprehensive Income (Topic 220): Presentation of Comprehensive Income</i>, which requires an entity to present total comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 does not change any of the components of comprehensive income, but it eliminates the option to present the components of other comprehensive income as part of the statement of stockholders equity. ASU 2011-05 is effective for the Company in its first quarter of fiscal 2013 and should be applied retrospectively. The Company is currently evaluating the impact of the adoption of ASU 2011-05 on its consolidated financial statements.</font></p> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><i>Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements</i></font></p> <p style="margin-top:6px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">In May 2011, the FASB issued ASU No.&#xA0;2011-04&#x2014;<i>Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs</i>, to provide a consistent definition of fair value and ensure that the fair value measurement and disclosure requirements are similar between U.S. GAAP and International Financial Reporting Standards. ASU 2011-04 changes certain fair value measurement principles and enhances the disclosure requirements particularly for level 3 fair value measurements. ASU 2011-04 is effective for the Company in its second quarter of fiscal 2012 and should be applied prospectively. The adoption of ASU 2011-04 did not have a material impact on the Company&#x2019;s consolidated financial statements.</font></p> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><i>Business Combinations</i></font></p> <p style="margin-top:6px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">In December&#xA0;2010, the FASB&#xA0;issued ASU No.&#xA0;2010-29, <i>Business Combinations (ASC Topic 805)&#x2014;Disclosure of Supplementary Pro Forma Information for Business Combinations</i>. ASU&#xA0;2010-29 requires a public entity to disclose revenue and earnings of the combined entity as though the business combination that occurred during the current year had occurred as of the beginning of the prior year. It also requires a description of the nature and amount of material, nonrecurring adjustments directly attributable to the business combination included in the reported revenue and earnings. The new disclosure was effective for the Company&#x2019;s first quarter of fiscal 2012 and did not have a material impact on the Company&#x2019;s consolidated financial statements.</font></p> <p style="font-size:1px;margin-top:18px;margin-bottom:0px"> &#xA0;</p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><i>Intangibles&#x2014;Goodwill and Other</i></font></p> <p style="margin-top:6px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">In December&#xA0;2010, the FASB issued ASU&#xA0;2010-28, <i>Intangibles&#x2014;Goodwill and Other (ASC Topic 350)</i>. ASU 2010-28 modifies Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining whether it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that an impairment may exist. ASU 2010-28 is effective for the Company in fiscal 2012. The Company does not believe that ASU 2010-28 will have a material impact on its consolidated financial statements.</font></p> <p style="margin-top:12px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">In September 2011, the FASB issued ASU No.&#xA0;2011-08, <i>Intangibles&#x2014;Goodwill and Other (Topic 350): Testing Goodwill for Impairment</i>. ASU 2011-08 allows entities to first assess qualitatively whether it is necessary to perform the two-step goodwill impairment test. If an entity believes, as a result of its qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, the quantitative two-step impairment test is required; otherwise, no further testing is required. ASU 2011-08 is effective for the Company beginning in fiscal 2013, although early adoption is permitted. The Company does not believe that ASU 2011-08 will have a material impact on its consolidated financial statements.</font></p> </div>
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3791000
holx Percentage Of Capital Stock In Foreign Subsidiaries
PercentageOfCapitalStockInForeignSubsidiaries
0.65 pure
holx Number Of Reporting Segments
NumberOfReportingSegments
4 pure
holx Debt Discount Amortization Period
DebtDiscountAmortizationPeriod
6 Year
holx Change In Other Assets
ChangeInOtherAssets
-948000
holx Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
2864000
holx Amended Transaction Price As Result Of Execution Of Amendment To Original Agreement
AmendedTransactionPriceAsResultOfExecutionOfAmendmentToOriginalAgreement
199500000
holx Business Acquisition Contingent Consideration Expense Total
BusinessAcquisitionContingentConsiderationExpenseTotal
79098000
holx Entity Wide Disclosure On Geographic Areas From External Customers Attributed To Foreign Countries
EntityWideDisclosureOnGeographicAreasFromExternalCustomersAttributedToForeignCountries
359100000
holx Debt Instrument Convertible Interest Expense Non Cash
DebtInstrumentConvertibleInterestExpenseNonCash
54882000
holx Contingent Consideration Compensation Expense
ContingentConsiderationCompensationExpense
44064000
holx Gross Unrecognized Tax Benefits
GrossUnrecognizedTaxBenefits
30600000
holx Liability Component Of Loss On Extinguishment
LiabilityComponentOfLossOnExtinguishment
39700000
holx Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
42347000
holx Payment For Tax Withholding Related To Vested And Released Restricted Stock Units
PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
5707000
holx Payment Of Additional Acquisition Consideration
PaymentOfAdditionalAcquisitionConsideration
9784000
holx Payment Of Contingent Consideration
PaymentOfContingentConsideration
51680000
holx Payment Of Contingent Consideration Liabilities Recorded At Fair Value
PaymentOfContingentConsiderationLiabilitiesRecordedAtFairValue
55888000
holx Payments To Manufacture Equipment Under Customer Usage Agreements
PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
32750000
holx Recapture Of Original Issuance Discount Of Notes Deducted For Tax Purposes
RecaptureOfOriginalIssuanceDiscountOfNotesDeductedForTaxPurposes
59000000
holx Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt For Derecognition
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtForDerecognition
41600000
holx Debt Instrument Offering Price Percentage
DebtInstrumentOfferingPricePercentage
1.00 pure
holx Estimated Percentage Of Providing Sensitivity Of Goodwill Impairment Test
EstimatedPercentageOfProvidingSensitivityOfGoodwillImpairmentTest
0.10 pure
holx Number Of Days To Remedy Event Of Default For Failure To Comply With Reporting Obligations Of Convertible Notes
NumberOfDaysToRemedyEventOfDefaultForFailureToComplyWithReportingObligationsOfConvertibleNotes
90 Day
holx Weighted Average Common Stock Equivalents From Assumed Exercise Of Stock Options And Restricted Stock Units
WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits
2617000 shares
holx Share Based Compensation Percentage Of Forfeiture Rate Maximum
ShareBasedCompensationPercentageOfForfeitureRateMaximum
0.045 pure
holx Share Based Compensation Percentage Of Forfeiture Rate Minimum
ShareBasedCompensationPercentageOfForfeitureRateMinimum
0.00 pure
holx Maximum Trading Days Prior To Maturity Date In Which Can Settle Conversions
MaximumTradingDaysPriorToMaturityDateInWhichCanSettleConversions
35 pure
holx Purchase Orders And Other Contractual Obligations
PurchaseOrdersAndOtherContractualObligations
3407000
holx Annual Revolver Facility Committment Fee Percent
AnnualRevolverFacilityCommittmentFeePercent
0.0050 pure
holx Aggregate Principal Of High Yield Notes
AggregatePrincipalOfHighYieldNotes
1000000000
holx Coupon Rate On High Yield Notes
CouponRateOnHighYieldNotes
0.0625 pure
holx Total Restructuring Charges Under The Exit Or Disposal Plan
TotalRestructuringChargesUnderTheExitOrDisposalPlan
19980000
holx Redemption Price Before August One Two Thousand Fifteen
RedemptionPriceBeforeAugustOneTwoThousandFifteen
1.06250 pure
holx Redemption Price Senior Notes Change In Control
RedemptionPriceSeniorNotesChangeInControl
1.01 pure
holx Percent Of Holders Of Aggregate Principal Outstanding Declare Bankruptcy
PercentOfHoldersOfAggregatePrincipalOutstandingDeclareBankruptcy
0.25 pure
holx Time Period Of Failure To Pay Interest
TimePeriodOfFailureToPayInterest
30 Day
holx Number Of Days To Register Senior Notes
NumberOfDaysToRegisterSeniorNotes
180 Day
holx Number Of Days To Complete Senior Notes Exchange
NumberOfDaysToCompleteSeniorNotesExchange
270 Day
CY2011Q1 holx Amount Received On Approval
AmountReceivedOnApproval
12500000
CY2012Q2 holx Loss Contingencies Damages Award To Plaintiff
LossContingenciesDamagesAwardToPlaintiff
18800000
CY2008Q1 holx Transaction Price Of Sale Of Intellectual Property Assets
TransactionPriceOfSaleOfIntellectualPropertyAssets
82000000
CY2011Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
84502000
CY2011Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1304000
CY2011Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
8620000
CY2011Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
300000
CY2011Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
485000
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29325000
CY2011Q2 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
1000000
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
261784000 shares
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.45 pure
CY2011Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.185 pure
CY2011Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M18D
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
44424000
CY2011Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
78292000
CY2011Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7779000
CY2011Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
72981000
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
73916000
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2011Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
129141000
CY2011Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
77153000
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
36196000
CY2011Q2 us-gaap Costs And Expenses
CostsAndExpenses
377166000
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2012Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
8538000
CY2012Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1119000
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
695000
CY2011Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39755000
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
265167000 shares
CY2011Q2 us-gaap Cost Of Services
CostOfServices
42503000
CY2011Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36649000
CY2011Q2 us-gaap Revenues
Revenues
451082000
CY2011Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
18229000
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8228000
CY2011Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
14848000
CY2011Q2 us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
44877000
CY2011Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14794000
CY2011Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
372790000
CY2011Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
453000
CY2011Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
-629000
CY2011Q2 us-gaap Interest Expense
InterestExpense
28673000
CY2011Q2 us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
27818000
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.96
CY2011Q2 holx Reversal Of Federal Tax Expense Benefits
ReversalOfFederalTaxExpenseBenefits
8200000
CY2011Q2 holx Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
969000
CY2011Q2 holx Business Acquisition Contingent Consideration Expense Total
BusinessAcquisitionContingentConsiderationExpenseTotal
3790000
CY2011Q2 holx Entity Wide Disclosure On Geographic Areas From External Customers Attributed To Foreign Countries
EntityWideDisclosureOnGeographicAreasFromExternalCustomersAttributedToForeignCountries
104500000
CY2011Q2 holx Debt Instrument Convertible Interest Expense Non Cash
DebtInstrumentConvertibleInterestExpenseNonCash
19198000
CY2011Q2 holx Contingent Consideration Compensation Expense
ContingentConsiderationCompensationExpense
3161000
CY2011Q2 holx Payment Of Contingent Consideration Liabilities Recorded At Fair Value
PaymentOfContingentConsiderationLiabilitiesRecordedAtFairValue
4295000
CY2011Q2 holx Weighted Average Common Stock Equivalents From Assumed Exercise Of Stock Options And Restricted Stock Units
WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits
3383000 shares
CY2011Q4 holx Loss Contingencies Damages Award To Plaintiff
LossContingenciesDamagesAwardToPlaintiff
18800000
CY2012Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
15316000
CY2012Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
12424000
CY2012Q1 us-gaap Severance Costs
SeveranceCosts
207000
CY2012Q1 holx Amount Received Per Agreement
AmountReceivedPerAgreement
12500000
CY2012Q1 holx Lease Termination Charges
LeaseTerminationCharges
400000
CY2012Q1 holx Purchase Orders And Other Contractual Obligations
PurchaseOrdersAndOtherContractualObligations
2761000
CY2012Q1 holx Total Restructuring Charges Under The Exit Or Disposal Plan
TotalRestructuringChargesUnderTheExitOrDisposalPlan
18284000
CY2012Q1 holx Divestiture Charges
DivestitureCharges
18300000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-622000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26229000
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
264609000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.47 pure
CY2012Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.571 pure
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M18D
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
55007000
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
85635000
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
8754000
CY2012Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
76368000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
80527000
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
134062000
CY2012Q2 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
76939000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
23594000
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
389701000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007 pure
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
43421000
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
267294000 shares
CY2012Q2 us-gaap Cost Of Services
CostOfServices
46246000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14066000
CY2012Q2 us-gaap Revenues
Revenues
470228000
CY2012Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15119000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31413000
CY2012Q2 us-gaap Other Restructuring Costs
OtherRestructuringCosts
200000
CY2012Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
19885000
CY2012Q2 us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
45280000
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15733000
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
384593000
CY2012Q2 us-gaap Restructuring Charges
RestructuringCharges
136000
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-9528000
CY2012Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
13276000
CY2012Q2 us-gaap Severance Costs
SeveranceCosts
-69000
CY2012Q2 us-gaap Interest Expense
InterestExpense
25593000
CY2012Q2 us-gaap Debt Instrument Convertible Interest Expense
DebtInstrumentConvertibleInterestExpense
24539000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.10
CY2012Q2 holx Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
882000
CY2012Q2 holx Business Acquisition Contingent Consideration Expense Total
BusinessAcquisitionContingentConsiderationExpenseTotal
2226000
CY2012Q2 holx Entity Wide Disclosure On Geographic Areas From External Customers Attributed To Foreign Countries
EntityWideDisclosureOnGeographicAreasFromExternalCustomersAttributedToForeignCountries
125100000
CY2012Q2 holx Debt Instrument Convertible Interest Expense Non Cash
DebtInstrumentConvertibleInterestExpenseNonCash
16001000
CY2012Q2 holx Contingent Consideration Compensation Expense
ContingentConsiderationCompensationExpense
15502000
CY2012Q2 holx Restructuring Charges Recorded In Cost Of Product Sales
RestructuringChargesRecordedInCostOfProductSales
1500000
CY2012Q2 holx Weighted Average Common Stock Equivalents From Assumed Exercise Of Stock Options And Restricted Stock Units
WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits
2685000 shares
CY2012Q2 holx Purchase Orders And Other Contractual Obligations
PurchaseOrdersAndOtherContractualObligations
646000
CY2012Q2 holx Impairment Charges Related To Inventory And Equipment
ImpairmentChargesRelatedToInventoryAndEquipment
1100000
CY2012Q2 holx Charges Related To Purchase Orders And Other Contractual Obligations
ChargesRelatedToPurchaseOrdersAndOtherContractualObligations
400000
CY2012Q2 holx Total Restructuring Charges Under The Exit Or Disposal Plan
TotalRestructuringChargesUnderTheExitOrDisposalPlan
1696000
CY2012Q2 holx Divestiture Charges
DivestitureCharges
1700000

Files In Submission

Name View Source Status
0001193125-12-331820-index-headers.html Edgar Link pending
0001193125-12-331820-index.html Edgar Link pending
0001193125-12-331820.txt Edgar Link pending
0001193125-12-331820-xbrl.zip Edgar Link pending
d351031d10q.htm Edgar Link pending
d351031dex311.htm Edgar Link pending
d351031dex312.htm Edgar Link pending
d351031dex321.htm Edgar Link pending
d351031dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
holx-20120623.xml Edgar Link completed
holx-20120623.xsd Edgar Link pending
holx-20120623_cal.xml Edgar Link unprocessable
holx-20120623_def.xml Edgar Link unprocessable
holx-20120623_lab.xml Edgar Link unprocessable
holx-20120623_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending